Pfizer Venture Investments vs Sofinnova Partners
Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.
| Pfizer Venture Investments | Sofinnova Partners | |
|---|---|---|
| Type | Corporate VC | Venture capital |
| HQ | — | Paris |
| Founded | 2004 | 1972 |
| Check size | $5M – $20M | $540K – $27M |
| Stages | Seed, Series A, Series B, Series C, Growth, Late Stage | Pre-Seed, Seed, Series A, Series B, Growth, Late Stage |
| Sectors | AI & Machine Learning, Biotech, Healthtech, Medical Devices | AgTech, Biotech, Cleantech, Climate Tech, Deep Tech, Digital Health, FoodTech, Healthtech, Impact & Social Good, Longevity, Medical Devices, New Materials |
| AUM | — | $4.4B |
| Tracked investments | 186 | 159 |
| Exits (acquired/public) | 4 | — |
| Led rounds on record | — | 2 |
| Dated deals, last 24 mo | — | 1 |
Shared portfolio · 6
ArtiosMediar TherapeuticsMission TherapeuticsMozart TherapeuticsReflexionmedicalVectivBio
Frequently asked questions
- Do Pfizer Venture Investments and Sofinnova Partners invest together?
- Yes — Pfizer Venture Investments and Sofinnova Partners appear together in 6 tracked portfolio companies, including Artios, Mediar Therapeutics, Mission Therapeutics, Mozart Therapeutics, Reflexionmedical.
- How do Pfizer Venture Investments and Sofinnova Partners compare on check size?
- Pfizer Venture Investments typically writes checks of $5M – $20M, while Sofinnova Partners writes $540K – $27M.